
Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
Author(s) -
Guangzhi Ma,
Shi-Yong Sun
Publication year - 2021
Publication title -
oncoscience
Language(s) - English
Resource type - Journals
ISSN - 2331-4737
DOI - 10.18632/oncoscience.544
Subject(s) - osimertinib , action (physics) , resistance (ecology) , acquired resistance , medicine , biology , epidermal growth factor receptor , ecology , receptor , cancer , physics , quantum mechanics , erlotinib